Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001349297-26-000004

Director sold 10,000 shares at $34.90 ($349,000)

  • Director acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Fitzgerald Meghan · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $8.80 $88,000 52,963 D
2026-06-30 Sale : show line 2 in the form 10b5-1 −10,000 $34.90 $349,000 42,963 D
Open-market sales · 10,000 sh · avg $34.90 · $349,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −10,000 38,578 D
Loading xslF345X06/wk-form4_1783033435.xml…